News

November 27, 2017November 27, 2017

New Guidelines Established for Partial Breast Radiation in Cancer Patients

News

Experts have published updated guidelines for the appropriate and safe use of accelerated partial-breast irradiation (APBI) in the treatment of breast cancer. The study with the guidelines, “The American Brachytherapy ... Read more

November 22, 2017November 22, 2017

Overweight Women May Need More Mammograms, Study Contends

News

Overweight women might need mammograms more often because being overweight increases the risk that a tumor will become large before it is detected, researchers from Karolinska Institutet in Sweden argue ... Read more

November 17, 2017November 17, 2017

FDA Approves Faslodex in Combo with Verzenio for Women with Advanced Breast Cancer

News

The U.S. Food and Drug Administration (FDA) expanded to use of AstraZeneca’s Faslodex (fulvestrant) to include it in combination with Verzenio (abemaciclib) to treat HR-positive, HER2-negative advanced or metastatic breast ... Read more

November 15, 2017November 15, 2017

European Commission Approves Faslodex-Ibrance Combo for Advanced Breast Cancer

News

The European Commission (EC) has extended the approval of AstraZeneca‘s breast cancer therapy Faslodex (fulvestrant) to be used in combination with Ibrance (palbociclib) for advanced breast cancers. The combination can now be used ... Read more

November 13, 2017November 13, 2017

Novartis to Request Kisqali’s Approval to Treat Premenopausal Women on Basis of Phase 3 Trial

News

Novartis plans to begin work with regulatory authorities to request that Kisqali (ribociclib) be approved as a first-line treatment for premenopausal women with HR-positive, HER2-negative advanced breast cancer. This decision ... Read more

November 8, 2017

BriaVax Breast Cancer Vaccine Development Going According to Plan, Company Says

News

BriaCell Therapeutics’ Phase 1/2a study of the breast cancer vaccine BriaVax is proceeding according to plan, the company recently announced. Six patients with advanced breast cancer have received the therapeutic ... Read more

November 6, 2017November 6, 2017

Alisertib, TAK-228 Combo Shows Promise for Treating Triple-Negative Breast Cancer

News

New data presented at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Meeting, in Philadelphia, demonstrated that using alisertib along with TAK-228, two of Takeda‘s investigational therapies, was more effective in patients with ... Read more

November 3, 2017November 3, 2017

Cryotherapy, as Frozen Gloves and Socks During Chemo, May Ease Neuropathy in Patients

News

Cryotherapy, which makes use of the beneficial properties of extremely cold temperatures, could help prevent damage in the peripheral nerves of patients receiving chemotherapy, a study suggests. Patients given frozen gloves ... Read more

November 2, 2017November 2, 2017

‘Rollover’ Trial to Test Breast Cancer Vaccine, BriaVax, in Combo with Yervoy or Keytruda

News

A “rollover” clinical trial of BriaVax — used in combination with Keytruda (pembrolizumab) or Yervoy (ipilimumab) — will soon begin to treat women with advanced breast cancer who did not respond ... Read more

October 30, 2017October 30, 2017

Double Mastectomy Linked to More Work Absences for Women with Early-Stage Breast Cancer

News

Double mastectomy, an aggressive surgical procedure to remove both breasts, increases the chances that early stage breast cancer patients will miss work for longer periods or stop working entirely, a ... Read more